Drug information for CYKLOKAPRON

Form Dosage Status Therapeutic Equivalence Active Ingred Ref. Sponsor Document
INJECTABLE; INJECTION 100MG/ML Prescription AP (Reference Drug) TRANEXAMIC ACID Tranexamic Acid PHARMACIA AND UPJOHN 19281
2011-02-02 Letter

2011-01-31 Label

2009-01-30 Letter

2009-01-02 Label

2008-12-24 Letter

2001-06-18 Review

2001-03-27 Letter

1999-09-09 Letter
TABLET; ORAL 500MG Discontinued   TRANEXAMIC ACID Tranexamic Acid PHARMACIA AND UPJOHN 19280
1999-09-09 Letter

1999-09-09 Review

Drug Adverse Effects information for CYKLOKAPRON

Role code Indications Reaction # Reports
PS MENORRHAGIA DIZZINESS 1
PS MENORRHAGIA HYPERSENSITIVITY 1
PS MENORRHAGIA HYPOAESTHESIA 1
PS MENORRHAGIA MYOCARDIAL INFARCTION 1
C ACQUIRED HAEMOPHILIA WITH ANTI FVIII, XI, OR XIII CARDIOPULMONARY FAILURE 1
C ACQUIRED HAEMOPHILIA WITH ANTI FVIII, XI, OR XIII STAPHYLOCOCCAL SEPSIS 1
C CONSTIPATION PROPHYLAXIS ACCIDENTAL DEATH 1
C CONSTIPATION PROPHYLAXIS ROAD TRAFFIC ACCIDENT 1
C FACTOR IX DEFICIENCY ACCIDENTAL DEATH 1
C FACTOR IX DEFICIENCY ROAD TRAFFIC ACCIDENT 1
C HAEMOPHILIA CARDIOPULMONARY FAILURE 1
C HAEMOPHILIA STAPHYLOCOCCAL SEPSIS 1
C IDIOPATHIC THROMBOCYTOPENIC PURPURA PULMONARY EMBOLISM 1
C MYELODYSPLASTIC SYNDROME LUNG NEOPLASM MALIGNANT 1
C MYELODYSPLASTIC SYNDROME PNEUMONIA FUNGAL 1
C MYELODYSPLASTIC SYNDROME THROMBOCYTOPENIA 1
C PROCOAGULANT THERAPY ACCIDENTAL DEATH 1
C PROCOAGULANT THERAPY ROAD TRAFFIC ACCIDENT 1
C PRODUCT USED FOR UNKNOWN INDICATION CARDIOPULMONARY FAILURE 13
C PRODUCT USED FOR UNKNOWN INDICATION STAPHYLOCOCCAL SEPSIS 13
C PROPHYLAXIS LUNG NEOPLASM MALIGNANT 1
C PROPHYLAXIS PNEUMONIA FUNGAL 1
C PROPHYLAXIS THROMBOCYTOPENIA 1
Ads by Google